Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proarrhythmia.

D M Roden1, M E Anderson

  • 1Division of Clinical Pharmacology, Vanderbilt University School of Medicine, 532 Medical Research Building I, Nashville, TN 37232, USA. dan.roden@vanderbilt.edu

Handbook of Experimental Pharmacology
|April 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Androgenic effects on ventricular repolarization: A translational study from the international pharmacovigilance database to iPSC-cardiomyocytes.

Annales d'endocrinologie·2020
Same author

Interaction of Concentration and Temperature of Acetic Acid Solution on Reduction of Various Species of Microorganisms on Beef Surfaces.

Journal of food protection·2019
Same author

Counts of Six Types of Bacteria on Lamb Carcasses Dipped or Sprayed with Acetic Acid at 25° or 55°C and Stored Vacuum Packaged at 0°C.

Journal of food protection·2019
Same author

Evaluation of Swab and Tissue Excision Methods for Recovering Microorganisms from Washed and Sanitized Beef Carcasses <sup>1,</sup> <sup>2</sup>.

Journal of food protection·2019
Same author

Microbial Decontamination and Weight of Carcass Beef as Affected by Automated Washing Pressure and Length of Time of Spray <sup>1</sup>.

Journal of food protection·2019
Same author

A Simple Qualitative Method for Detecting Cleanliness of Food Contact Surfaces.

Journal of food protection·2019
Same journal

Endothelial Cell Phenotypic Plasticity in Atherosclerosis.

Handbook of experimental pharmacology·2026
Same journal

Endothelial Dysfunction and Neurovascular Alterations in Autism Spectrum Disorder.

Handbook of experimental pharmacology·2026
Same journal

Molecular Mechanisms of Endothelial Shear Stress Mechanotransduction in Health and Disease.

Handbook of experimental pharmacology·2026
Same journal

Microvasculature of the Pancreatic Islets of Langerhans in Health and Diabetes.

Handbook of experimental pharmacology·2026
Same journal

Mechanisms of Actions of Physiological, Pharmacological, and Toxicological Dietary Bioactive Inorganic Boron.

Handbook of experimental pharmacology·2026
Same journal

BNCT Plus Luminescence: New Paradigm for Boron-Containing Drug Design.

Handbook of experimental pharmacology·2026
See all related articles

Antiarrhythmic drugs can cause dangerous heart rhythms, a phenomenon known as proarrhythmia. This risk is more common than previously thought and is now a key consideration in drug development and patient treatment.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • The phenomenon of proarrhythmia, where antiarrhythmic drugs induce or worsen cardiac arrhythmias, has been recognized for decades.
  • Historically considered rare and unpredictable, proarrhythmia is now understood to be more prevalent and associated with increased mortality in certain patient populations.

Purpose of the Study:

  • To highlight the shift in antiarrhythmic drug pharmacology, moving from a focus solely on efficacy to a dual consideration of efficacy and proarrhythmic risk.
  • To emphasize the critical role of avoiding proarrhythmia in the development of new antiarrhythmic medications.

Main Methods:

  • Review of historical and contemporary understanding of proarrhythmia.
  • Analysis of clinical implications and drug development strategies related to proarrhythmic risk.

Related Experiment Videos

Main Results:

  • Proarrhythmia is a significant factor influencing clinical antiarrhythmic drug selection.
  • Avoiding proarrhythmia is a central objective in the development of novel antiarrhythmic agents.
  • Advances in understanding the mechanisms of proarrhythmia allow for risk stratification, moving beyond the concept of idiosyncratic reactions.

Conclusions:

  • Proarrhythmia is a major concern in antiarrhythmic drug therapy, impacting both clinical practice and drug discovery.
  • While individual unpredictdictability persists, mechanistic insights are improving risk assessment for proarrhythmia.
  • Ongoing research across multiple levels (genetic to clinical) promises further advancements in managing and preventing proarrhythmic events.